Goldman Sachs Estimates Weight Loss Drug Could Accelerate Growth of US Economy
Increased utilization of GLP-1 weight loss medications could significantly accelerate the growth of the United States economy, Goldman Sachs projects.
Increased utilization of GLP-1 weight loss medications could significantly accelerate the growth of the United States economy, Goldman Sachs projects.
Despite optimism on Wall Street looming recession threatens to impact stock market with potential declines of up to 26% in the S&P 500.
Prospect of soft landing for US economy has dissipated with a recession anticipated by mid-2024, according to insights from Citi's chief economist.
Equity markets reflecting valuations reminiscent of those observed just before onset of 2022 bear market according to Gundlach, CEO of DoubleLine.
Musk joins the likes of Jamie Dimon and Jerome Powell in expressing concern about the $34 trillion Uncle Sam owes.
Leading market experts, including Jeremy Grantham and Jeffrey Gundlach, anticipate significant downturns for the equity market.
Equity valuations appear inflated, poised for correction,escalating U.S. debt levels are cause for alarm, and Musk's high compensation.